Surgical management of invasive pulmonary aspergillosis in neutropenic patients

被引:63
|
作者
Bernard, A
Caillot, D
Couaillier, JF
Casasnovas, O
Guy, H
Favre, JP
机构
[1] UNIV BURGUNDY,DEPT SURG,DIJON,FRANCE
[2] UNIV BURGUNDY,DEPT CLIN HEMATOL,DIJON,FRANCE
[3] UNIV BURGUNDY,DEPT RADIOL,DIJON,FRANCE
来源
ANNALS OF THORACIC SURGERY | 1997年 / 64卷 / 05期
关键词
D O I
10.1016/S0003-4975(97)00858-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The aim of our study was to clarify the indications for operation in invasive pulmonary aspergillosis. Methods. Nineteen patients with hematologic malignancy, in whom invasive pulmonary aspergillosis developed during the course of neutropenia, had operations. Neutropenia lasted 28 days (range, 15 to 45 days). The preoperative diagnosis of invasive pulmonary aspergillosis was based on computed tomographic scan findings (halo or air crescent signs). Results. Eight patients underwent emergency operations, before marrow recovery, for prevention of massive hemoptysis. The criterion for operation was an aspergillosis lesion that contacted the pulmonary artery on computed tomography. A lobectomy was performed in all cases. A sleeve resection of the pulmonary artery was necessary on two occasions. There was one postoperative death due to extensive aspergillosis. The length of hospitalization after operation was 13 days (range, 6 to 18 days). Seven patients were treated by elective resection of a residual mass (before hematologic therapy in 6 Cases). The types of resection performed were lobectomy (n = 4), lingulectomy (n = 1), and wedge resection (n = 2). There were no postoperative deaths. The average length of stay before discharge from the hospital was 11 days (range, 7 to 20 days). The surgical resection was performed as a diagnostic procedure in the 4 remaining patients after an allotted time of 14 days (range, 4 to 24 days) from initiation of antifungal therapy. Conclusions. The combination of antifungal agents and surgical resection is an efficient strategy for the treatment of invasive pulmonary aspergillosis iii patients with hematologic malignancy.
引用
收藏
页码:1441 / 1447
页数:7
相关论文
共 50 条
  • [21] Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients
    Park, S. Y.
    Kim, S. -H.
    Choi, S. -H.
    Sung, H.
    Kim, M. -N.
    Woo, J. H.
    Kim, Y. S.
    Park, S. -K.
    Lee, J-H.
    Lee, K. -H.
    Lee, S. -G.
    Hans, D. J.
    Lee, S-O
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (04) : 309 - 315
  • [22] Itraconazole in the prevention of high risk invasive pulmonary aspergillosis (IPA) in neutropenic patients
    Lamy, T
    Bernard, M
    Courtois, A
    Jacquelinet, C
    Chevrier, S
    Dauriac, C
    Grulois, I
    LePrise, PY
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1171 - 1171
  • [23] Therapeutic granulocyte transfusions in neutropenic patients with invasive pulmonary aspergillosis and haematological malignancies
    Drognitz, K.
    Eckenweiler, M.
    Herzog, R.
    Luebbert, M.
    Illerhaus, G.
    Bertz, H.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S214 - S214
  • [24] Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis
    Gossot, D
    Validire, P
    Vaillancourt, R
    Socié, G
    Esperou, H
    Devergie, A
    Guardiola, P
    Grunenwald, D
    Gluckman, E
    Ribaud, P
    [J]. ANNALS OF THORACIC SURGERY, 2002, 73 (01): : 240 - 244
  • [25] Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: A case report
    Myoken, Y
    Sugata, T
    Kyo, T
    Fujihara, M
    Mikami, Y
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1997, 26 (01) : 51 - 53
  • [26] Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
    Caillot, D
    Casasnovas, O
    Bernard, A
    Couaillier, JF
    Durand, C
    Cuisenier, B
    Solary, E
    Piard, F
    Petrella, T
    Bonnin, A
    Couillault, G
    Dumas, M
    Guy, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 139 - 147
  • [27] INVASIVE ASPERGILLOSIS IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL DISORDERS
    SHPILBERG, O
    DOUER, D
    GOLDSCHMIEDREOUVEN, A
    BLOCK, C
    BENBASSAT, I
    RAMOT, B
    [J]. LEUKEMIA & LYMPHOMA, 1991, 4 (04) : 257 - 262
  • [28] Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: A role for isavuconazole
    Bassetti, Matteo
    Carnelutti, Alessia
    Righi, Elda
    [J]. IDCASES, 2018, 12 : 7 - 9
  • [29] Indications, complications and prediction of outcome of lung resection for invasive pulmonary aspergillosis in neutropenic patients
    Tamm, M
    Matt, P
    Gambazzi, F
    Bernet, F
    Gratwohl, A
    [J]. CHEST, 2004, 126 (04) : 776S - 776S
  • [30] Pharmacodynamics of posaconazole in a neutropenic animal model of invasive pulmonary Aspergillosis
    Groll, A. H.
    Mickiene, D.
    Petraitiene, R.
    Petraitis, V.
    Piscitelli, S.
    Walsh, T. J.
    [J]. MYCOSES, 2009, 52 : 24 - 25